Corporate Banner
Satellite Banner
Technology Networks Header
Friday, May 24, 2013
Technology Networks
 
Register | Sign in
Home Page
  News
Return to the previous page

Rockland Immunochemicals Awarded Phase II SBIR Funding

Published: Tuesday, October 16, 2012
Last Updated: Tuesday, October 16, 2012
Bookmark and Share
Company receives grant for 1 million dollars to develop Akt/mTOR signaling pharmacodynamics assay.

Full access to this article is for registered users only.
Registration is free-of-charge and allows access to all content on our web communities.

Already registered? Then please log in at the top of the page.

Print Page

Scientific News
Common Childhood Asthma Not Rooted in Allergens, Inflammation
Discovery of origins of a unique form of asthma may lead to a precision medicine approach to treatment.
Infection Makes Mosquitoes Immune to Malaria Parasites
Study highlights the potential of using Wolbachia in malaria control.
Depression Linked to Telomere Enzyme, Aging, Chronic Disease
The first symptoms of major depression may be behavioral, but the common mental illness is based in biology — and not limited to the brain.
Program for Breakthrough Biomedical Research to Celebrate 15 Years
A program that fosters basic science projects of potentially high impact is celebrating 15 years of discovery at UC San Francisco.
Osteoarthritis Progression Halted in Mice
If successful in humans, joint replacement surgery might be avoidable.
Vitamin D Could Provide New and Effective Treatments for Asthma
Vitamin D has the potential to significantly reduce the symptoms of asthma, according to a new study from the Medical Research Council (MRC).
Nuvo Research Announces Scientific Presentation at the Annual Meeting of AAI
Data evaluating WF10's therapeutic impact on signs and symptoms of experimentally induced rheumatoid arthritis in mice.
Yale Cancer Center Carves New Path in Immunotherapy
Cancer immunotherapy is showing promise in treating patients with a variety of advanced, metastatic tumors.
UCSF Scientists Use Human Stem Cells to Generate Immune System in Mice
Raising hopes for cell-based therapies, UC San Francisco researchers have created the first functioning human thymus tissue from embryonic stem cells in the laboratory.
Hormone May Help Treat Diabetes
Betatrophin prompts cells in the pancreas to multiply and produce more insulin.
Skyscraper Banner
Skyscraper Banner
Follow TechNetcom1 on Twitter
Technology Networks Ltd. on LinkedIn
Get The App
Go to LabTube.tv
Go to ePosters.net